Share this page on LinkedIn
Share This Page on Google+
Share This Page on Twitter
tell someone about this page print this page
You are here: Contents > 2012 > Volume 21 Number 3 May 2012 > AORTIC VALVE DISEASE > Transapical Valve-in-Valve Implantation for Regurgitant Stented Aortic Bioprostheses

Transapical Valve-in-Valve Implantation for Regurgitant Stented Aortic Bioprostheses

Peter Wenaweser, Thomas Pilgrim, Stephan Windecker, Stefan Stortecky, Thierry Carrel, Alexander Kadner

Departments of Cardiology and Cardiovascular Surgery, Swiss Cardiovascular Center Bern, University Hospital, Bern, Switzerland

Transcatheter aortic valve implantation (TAVI) is rapidly evolving as an alternative treatment option for elderly patients with severe symptomatic aortic stenosis and excessive risk for surgical intervention. Transcatheter valve-in-valve implantation is an alternative approach to redo-surgery for patients with degeneration of a bioprosthetic valve.

Herein are reported three cases of successful transcatheter aortic valve-in-valve implantation for severely regurgitant bioprosthetic valves with a clinical follow up of more than 12 months.


The Journal of Heart Valve Disease 2012;21:344-349

Transapical Valve-in-Valve Implantation for Regurgitant Stented Aortic Bioprostheses

Click the above hyperlink to view the article, right click (Ctrl click on a Mac) to open in a new browser window or tab.

Purchase this Article

Please click the button below to purchase this article. Single article purchases are provided at $50.00 per article. Upon clicking the button below, single article user account subscription details are requested and, upon successful payment, a single article user account is created. Single articles are availble in your account for seven days after purchase.